Vaxcyte (NASDAQ:PCVX) reported quarterly earnings results on February 24, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of…
Vaxcyte (NASDAQ:PCVX) reported quarterly earnings results on February 24, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-1.80, missing the consensus estimate of $-1.49 by $0.31 per share. Revenue came in at , meeting the estimate of .
Vaxcyte's stock moved following the earnings release. The stock currently trades at $64.48 with a market capitalization of $5.8B.
Current market data
NASDAQ · PCVX
$59.84
Down: -$1.32 · -2.16%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
price ·
institutional ·
sec_filing ·
sec_filing ·
